• Home
  • Products & Services
    • T-SPOT®.TB
    • T-Cell Xtend®
    • Testing Services
    • CERTIMMUNE
  • Science
    • Technology
    • Product Pipeline
    • Clinical Studies
    • Investigator Initiated Studies
    • Medical Education
      • Applying for a Grant
  • Company
    • About Us
    • Our Vision
    • Our Values
  • News & Events
    • News
    • Industry Events
    • Awards & Recognition
  • Join Our Team
Harnessing the power of T cell measurement
Contact Us
  • Contact Us
  • Office Locations
  • Worldwide Distributors
  • Home
  • Products & Services
    • T-SPOT®.TB
    • T-Cell Xtend®
    • Testing Services
    • CERTIMMUNE
    • Terms and Conditions of Sale
  • Science
    • Technology
    • Product Pipeline
    • Clinical Studies
    • Investigator Initiated Studies
    • Medical Education
      • Applying for a Grant
  • Company
    • About Us
    • Our Vision
    • Our Values
    • Our History
  • News & Events
    • News
    • Industry Events
    • Awards & Recognition
  • Join Our Team
  • News
  • Industry Events
  • Awards & Recognition

News

  • Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study
  • PerkinElmer to Acquire Oxford Immunotec Global PLC
  • Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week
  • Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, for IVD Use in South Korea
  • Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Discovery SARS-CoV-2 Kit for the Measurement of the T cell Immune Response to SARS-CoV-2 Infection in Japan
  • Oxford Immunotec to Hold a Virtual Investor Event on December 17, 2020
  • Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measured Using Oxford Immunotec’s T-SPOT® Technology – is Published by Public Health England and Oxford Immunotec
  • Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell SelectTM Reagent Kit
  • Oxford Immunotec Reports Third Quarter 2020 Financial Results
  • UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses in New COVID Vaccine Trials
Page: Prev 1 2 3 4 … 23 Next
  • Site Map|
  • Terms of Use|
  • Privacy Policy|
T-SPOT, T-Cell Xtend, T-Cell Select and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd. | © 2022 Oxford Immunotec USA, Inc.
This site uses cookies to store information on your computer. We use necessary cookies that are essential to make our site work; and non-necessary cookies that help us improve the user experience. Enable/Disable CookiesACCEPTLEARN MORE
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT